RxDoctor Payments Data

Paul Walker, MD

Otolaryngology · Fleming Island, FLNPI 1285627497

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (44.6%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. Optinose US, Inc. accounts for 67.9% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2021 at $3,109 and has fallen 90.2% since, to $304 in 2025.

$4,484in general payments, 2019–2025

Across 50 payments — averaging $89.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Optinose US, Inc.$3K
  • Stryker$596
  • Medtronic$257
  • Regeneron Healthcare Solutions, Inc.$246
  • GSK$72
  • Smith+Nephew$67
  • plus $202 from 7 others
$209,879in research payments, 2019–2025

Across 1 payment — averaging $209,879 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$210K

What the payments were for

  • Consulting fees$2,00045%
  • Speaking & faculty fees$74017%
  • Food & beverage$1,74439%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,484 in reported general payments places this provider in the 75th percentile of 586 otolaryngology providers in Florida.

See all otolaryngology providers in Florida

Medicare billing

Part B allowed, 2024
$363,756
Medicare patients
633
Services billed
7,592

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Azelastine Hcl263$8,426
Mometasone Furoate20$4,574
Ipratropium Bromide139$3,437
Fluticasone Propionate46$815
Mupirocin59$467
CefuroximeCefuroxime Axetil22$326
Ofloxacin15$317
Methylprednisolone37$271
Ondansetron Hcl33$219
Cephalexin32$214
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen31$212

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Fleming Island

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →